Importantly, mutations in SF3B1, SRSF2 and U2AF1 result in different splicing alterations, largely affecting different genes, but with an enrichment in RNA splicing and transport, protein synthesis, mitochondrial dysfunction and signaling cascades, suggesting common mechanisms of action in MDS [84,114]. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.